Croda International Plc (LON:CRDA – Get Free Report) insider Stephen Oxley sold 1,339 shares of the business’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of GBX 3,214, for a total value of £43,035.46.
Stephen Oxley also recently made the following trade(s):
- On Friday, July 10th, Stephen Oxley acquired 5 shares of Croda International stock. The stock was acquired at an average cost of GBX 2,859 per share, for a total transaction of £142.95.
- On Wednesday, June 10th, Stephen Oxley bought 5 shares of Croda International stock. The stock was acquired at an average price of GBX 2,965 per share, for a total transaction of £148.25.
Croda International Stock Performance
Croda International stock opened at GBX 3,265 on Monday. The business’s 50-day moving average price is GBX 3,035.92 and its two-hundred day moving average price is GBX 2,931.29. Croda International Plc has a 12-month low of GBX 2,426.77 and a 12-month high of GBX 3,352. The stock has a market cap of £4.55 billion, a PE ratio of 57.38, a P/E/G ratio of 1.40 and a beta of 0.92. The company has a quick ratio of 2.25, a current ratio of 2.57 and a debt-to-equity ratio of 36.06.
Wall Street Analyst Weigh In
CRDA has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a GBX 3,300 target price on shares of Croda International in a research note on Wednesday, July 29th. Jefferies Financial Group restated a “buy” rating and issued a GBX 3,500 target price on shares of Croda International in a research report on Wednesday, July 29th. Berenberg Bank reissued a “buy” rating and set a GBX 3,600 price target on shares of Croda International in a research note on Wednesday, July 29th. Finally, Citigroup upped their price objective on shares of Croda International from GBX 3,050 to GBX 3,200 and gave the company a “neutral” rating in a research note on Wednesday, July 29th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 3,390.
Check Out Our Latest Report on Croda International
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Recommended Stories
- Five stocks we like better than Croda International
- Albemarle’s Blowout Quarter Shows Why Lithium Still Matters
- Can DICK’S Turn Foot Locker Into a Winner?
- Why Dutch Bros Plunged Despite a Q2 Earnings Beat and Record Revenue
- Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
